BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27866196)

  • 21. TGF-beta and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways.
    Weiss RH; Yabes AP; Sinaee R
    Kidney Int; 1995 Sep; 48(3):738-44. PubMed ID: 7474659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells.
    Paul A; Doherty K; Plevin R
    Br J Pharmacol; 1997 Mar; 120(5):940-6. PubMed ID: 9138702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C-δ (PKC-δ) and PKC-α mediate Ca(2+)-dependent increases in CNP mRNA in human vascular cells.
    Mendonça MC; Koles N; Sellitti DF
    Vascul Pharmacol; 2012; 57(2-4):98-104. PubMed ID: 22583821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate G1/S inhibition.
    Sasaguri T; Kosaka C; Hirata M; Masuda J; Shimokado K; Fujishima M; Ogata J
    Exp Cell Res; 1993 Sep; 208(1):311-20. PubMed ID: 8359225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells.
    Porreca E; Ciccarelli R; Di Febbo C; Cuccurullo F
    Atherosclerosis; 1993 Dec; 104(1-2):137-45. PubMed ID: 8141837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
    Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
    Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoforms of protein kinase C involved in phorbol ester-induced sphingosine 1-phosphate receptor 1 phosphorylation and desensitization.
    Morquecho-León MA; Bazúa-Valenti S; Romero-Ávila MT; García-Sáinz JA
    Biochim Biophys Acta; 2014 Feb; 1843(2):327-34. PubMed ID: 24239722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of protein kinase C-epsilon and its regulatory domains in fibroblasts inhibits phorbol ester-induced phospholipase D activity.
    Kiss Z; Petrovics G; Olàh Z; Lehel C; Anderson WB
    Arch Biochem Biophys; 1999 Mar; 363(1):121-8. PubMed ID: 10049506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradykinin augments EGF-induced airway smooth muscle proliferation by activation of conventional protein kinase C isoenzymes.
    Gosens R; Grootte Bromhaar MM; Maarsingh H; ten Damme A; Meurs H; Zaagsma J; Nelemans SA
    Eur J Pharmacol; 2006 Mar; 535(1-3):253-62. PubMed ID: 16529737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation by protein kinase C of transforming growth factor-beta 1 action on the proliferation of vascular smooth muscle cells from spontaneously hypertensive rats.
    Saltis J; Bobik A
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):573-5. PubMed ID: 8800588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of non-classical protein kinase C isoenzymes in a human T cell line.
    Keenan C; Kelleher D; Long A
    Eur J Immunol; 1995 Jan; 25(1):13-7. PubMed ID: 7843222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression.
    Xu W; Guo T; Zhang Y; Jiang X; Zhang Y; Zen K; Yu B; Zhang CY
    Exp Cell Res; 2011 May; 317(8):1083-92. PubMed ID: 20955697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actin-based features negatively regulated by protein kinase C-epsilon.
    Li Y; Urban JM; Cayer ML; Plummer HK; Heckman CA
    Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1002-13. PubMed ID: 17035302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells.
    Wang Y; Yan T; Wang Q; Wang W; Xu J; Wu X; Ji H
    Biochem Biophys Res Commun; 2008 Oct; 375(1):151-5. PubMed ID: 18687307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta.
    Afrasiabi E; Ahlgren J; Bergelin N; Törnquist K
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):26-35. PubMed ID: 18541361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways.
    Stapleton CM; Joo JH; Kim YS; Liao G; Panettieri RA; Jetten AM
    Exp Cell Res; 2010 Feb; 316(4):507-16. PubMed ID: 20025870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.
    Lin WW; Chen BC
    Br J Pharmacol; 1998 Dec; 125(7):1601-9. PubMed ID: 9884090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute phorbol ester treatment inhibits thapsigargin-induced cell death in porcine aortic smooth muscle cells.
    Lin KC; Liu PS; Peng PY; Chueh SH
    Eur J Pharmacol; 2012 Jul; 686(1-3):8-15. PubMed ID: 22542660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells.
    Pukac LA; Ottlinger ME; Karnovsky MJ
    J Biol Chem; 1992 Feb; 267(6):3707-11. PubMed ID: 1371276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.